SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer

Published:2018-02 Issue:2 Volume:363 Page:160-170
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Xu Ying,Miao Chunying,Jin Chengjuan,Qiu Chunping,Li Yinuo,Sun Xiaomei,Gao Min,Lu Nan,Kong Beihua

Funder

National Clinical Research Center for Gynecological Oncology

National Natural Science Foundation of China

Shandong Provincial Natural Science Foundation

Publisher

Elsevier BV

Subject

Cell Biology

Reference33 articles.

1. Ovarian cancer;Hennessy;Lancet,2009

2. Ovarian cancer, version 1.2016, NCCN clinical practice guidelines in oncology;Morgan;J. Natl. Compr. Cancer Netw.,2016

3. The changing view of high-grade serous ovarian cancer;Berns;Cancer Res.,2012

4. Cancer statistics, 2010;Jemal;CA Cancer J. Clin.,2010

5. Epithelial ovarian cancer - more data, more questions?;Aust;Wien. Med. Wochenschr.,2014

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes;Cellular and Molecular Life Sciences;2024-08-22

2. The dual role of SUSD2 in cancer development;European Journal of Pharmacology;2024-08

3. Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models;2024-07-29

4. Exploring the Potential of Natural Killer Cell-Based Immunotherapy in Targeting High-Grade Serous Ovarian Carcinomas;Vaccines;2024-06-18

5. Sushi Domain Containing 2 Dysfunction Contributes to Cancer Progression in Patients with Bladder Cancer;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3